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Background: Psychodynamic and cognitive-behavioral group therapies are frequently applied in day hospitals for
the treatment of anxiety disorders and comorbid depressive or personality disorders in Poland and other Eastern
European countries. Yet there is not enough evidence as to their effectiveness in this environment; this study
addresses this gap. The aim of the study is to determine the effectiveness of these two kinds of day treatment care
consisting of intensive, short-term group psychodynamic and cognitive-behavioral therapy, for patients with anxiety
disorders and/or comorbid depressive or personality disorders. Our objectives are to: 1) show the effectiveness of
each treatment in a day-care setting relative to the wait-list control group; 2) demonstrate the relative short- and
long-term effectiveness of the two active treatments; 3) carry out a preliminary examination of the predictors and
moderators of treatment response; 4) carry out a preliminary examination of the mediators of therapeutic change;
and 5) compare the impact of both methods of treatment on the outcome of the measures used in this study.
Methods/Design: In this randomized controlled trial, a total of 199 patients with anxiety disorders and comorbid
depressive and/or personality disorders will be assigned to one of three conditions: 1) psychodynamic group therapy;
2) cognitive-behavioral group therapy; or 3) wait-list control group. The therapy will last 12 weeks. Both treatments will
be manualized (the manuals will address comorbidity). Primary outcome measures will include self-reported symptoms
of anxiety, observer-rated symptoms of anxiety, global improvement, and recovery rate. Secondary outcome measures
will include the number of pathological personality traits, depression, self-esteem, defense mechanisms, beliefs about
self and others, interpersonal problems, object relations, parental bonding, meta-cognition, and quality of life. Measures
will be taken at baseline, post-treatment, and at six months following the end of therapy.
Discussion: The rationale is to investigate how effectively anxiety disorders and/or comorbid depressive or personality
disorders can be treated in a day hospital setting, typical of the Polish health care system, during a three-month
treatment period.
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Group psychotherapy of severe neurotic disorders in a day
unit setting has been widely developed in Eastern European
countries since the 1960s. This was offered for patients
who, due to the disabling intensity of their symptoms, could
not function normally and therefore had poor quality of life,
and were admitted for three months intensive treatment in
day clinic settings. It usually took place five days per week
for five to seven hours each day, and took the form of
group psychotherapy [57]. This intensive short-term format
is still the most available type of psychotherapy, reimbursed
by the National Health Service in Poland, where 300 such
wards exist today. Every year, approximately 8,000 individ-
uals suffering from anxiety and/or personality disorders
are treated in this setting in day clinics in Poland [38]. In
spite of its popularity, the effectiveness of psychodynamic
and cognitive-behavioral 12-week intensive group psycho-
therapy treatment for anxiety disorders in a day clinic set-
ting has never been tested or compared with current
methodological scrutiny, which has prompted the current
research project.
Anxiety disorders are among the most prevalent mental
disorders, with a lifetime prevalence of 30 % in the US [42]
and 9.9 % in Poland [52], according to a study that used a
similar methodology to that conducted in the US. Many
studies suggest that in some countries there is a strong co-
morbidity with personality disorders. A recent meta-
analysis of 125 studies [27] demonstrated that the risk of
comorbid anxiety disorders and personality disorders varied
from 35 to 52 %; the most frequently comorbid disorders
are Cluster C personality disorders, as classified by the
Diagnostic and Statistical Manual of Mental Disorders
(DSM-V). Epidemiological studies also show high comor-
bidity rates for anxiety and depressive disorders, ranging
from 40 to 80 % [39, 46]. Data on relationships between
comorbid mental disorders and treatment outcomes are
inconsistent. Reviews by Reich and Green [64] and Reich
and Vasile [65] including 38 studies have shown that co-
morbid anxiety disorders and personality disorders are
negatively related to treatment outcome. However, after
analyzing 15 studies, Dreessen and Arntz [21] did not share
these conclusions.
It should be noted that the comorbidity of anxiety dis-
orders and personality disorders in the population of
neurotic patients treated in day clinics seems to be
higher than that reported in other studies. The results of
one of our studies show that 125 out of 152 participants
(82.3 %) fulfilled the criteria for at least one personality
disorder (as assessed by the Structured Clinical Inter-
view for DSM-IV Personality Disorders Questionnaire -
II (SCID-II) [76]. The effectiveness of day care has been
investigated to a very small degree, especially with
regards to its frequent usage [50]. However, difficulties
in identifying the basic effective components of thetreatment, and the large diversity of the treatment pro-
grams make it difficult to generalize the results.
Among the small number of published studies on the ef-
fectiveness of psychotherapy in a day care setting, only four
were randomized controlled trials (RCTs). Three of those
studies compared psychotherapy in day care units to out-
patient psychotherapy [2, 19, 80], and one study used a
wait-list control group [63]. Tyrer et al. [80] found no sig-
nificant differences between day care and outpatient care
for anxiety disorders. Dick et al. [19] found a significant dif-
ference in improvement of personality disorder pathology
in favor of day care. In the first study, the psychotherapy
modality was not mentioned, and in the second, eclectic
psychotherapy was applied. In another study by Arnevik
et al. [2], day care treatment (18-week group psycho-
dynamic and cognitive-behavioral psychotherapy) was
compared to individual psychotherapy in patients with
personality disorders; no significant differences in im-
provement were observed between the two groups. Piper
et al. [63] found that day care patients suffering from
affective disorders and personality disorders experienced a
significant improvement that continued during follow-up
after eight months (18-week group psychodynamic psy-
chotherapy), as compared to patients in the wait-list con-
trol group. The authors of a Cochrane review of day care
versus outpatient care noticed that because of the small
number of existing studies, ‘there is only limited evidence
to justify the provision of day treatment programs and
transitional day hospital care, and no evidence to support
the provision of day care centers’ [50]. Existing data are
therefore not sufficient enough to justify the use of group
psychotherapy in day care, and more high-quality research
is needed. The question as to which treatment of the two
most widely used forms of therapy, psychodynamic or
cognitive-behavioral, is more effective also awaits an
answer. These questions are relevant in light of the large
expenditures incurred by the national health funds that
finance the treatment. They are also important to the issue
of health care in Poland, where this type of treatment
is very common.
Objectives
The main objective of the planned research is to evalu-
ate the clinical effectiveness of short-term, intensive,
psychodynamic, and cognitive-behavioral group psycho-
therapy for anxiety disorders and comorbid depressive
or personality disorders in day care conditions.
The more specific objectives are to: 1) show the effect-
iveness of each treatment in a day care setting relative to
the wait-list control group; 2) demonstrate the relative
short- and long-term effectiveness of the two active
treatments; 3) carry out a preliminary examination of
the predictors and moderators of treatment response; 4)
carry out a preliminary examination of the mediators of
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methods of treatment on the outcome of the measures
used in this study.
Methods/Design
Study design
This study is an RCT in which participants will be al-
located to one of three conditions: 1) psychodynamic
group therapy; 2) cognitive-behavioral group therapy;
or 3) the wait-list control group (WL). Participants
allocated to the wait list will commence treatment
after a 12-week waiting period. The total duration of
the study will be three years. Figure 1 shows the trial
design. The study protocol, information brochure, and
informed consent were approved by the Medical Eth-
ics Committee of Warsaw Medical University (refer-
ence number: KB/61/2010).
Study center
Both the protocol and the design comprise a part of the re-
search grant given to the II Department of Psychiatry at the
Medical University of Warsaw. The study will be carried
out at the day unit of the Wola Center for Mental Health atFig. 1 Flowchart of the trial designWola Hospital in Warsaw, which will be used as the clinical
setting for the II Department of Psychiatry of the Medical
University of Warsaw.Participant recruitment, inclusion and exclusion criteria
and randomization
Participants with anxiety disorders and comorbid personal-
ity disorders will be recruited from an outpatient clinic. Par-
ticipation is voluntary. Informed consent is given in writing
and signed with a personal signature. Participants may
withdraw their informed consent at any time, without any
consequences for their treatment. Randomization will take
place after informed consent has been obtained. Subjects
who meet all of the inclusion criteria will be randomized to
two modalities of treatments or to the wait list.
Patients from the wait list will continue pharmacological
treatment and will take part in monthly supportive con-
sultations. Crisis intervention will be offered when needed.
In accordance with the informed consent procedure, pa-
tients will not receive treatment in another clinic while
waiting for day-treatment care. After the waiting period
they will be randomized into two intervention groups.
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Table 1. The number of excluded patients and the rea-
sons for exclusion will be recorded. The diagnostic cri-
teria are based on the DSM-V system. Initial assessment
will be conducted with independent researchers who will
not be involved in the further interventions. It will in-
clude a pharmacological consultation by a psychiatrist,
personality diagnosis with SCID-II [24, 25], and diagno-
sis of clinical disorders with the Mini International
Neuropsychiatric Interview 51 (MINI) [71, 51]. Diagnosis
and evaluation for treatment will be carried out during
ambulatory sessions. The focus of the treatment is on
psychotherapy, but medication will be continued or initi-
ated if necessary during the screening procedure at least
four weeks before the beginning of group psychother-
apy (stable medical treatments with selective serotonin
re-uptake inhibitors or serotonin-norepinephrine reuptake
inhibitors, without dose changes during psychotherapy
unless necessary). Baseline measurements and final adjust-
ments of pharmacological treatment will be conducted
one day before the beginning of therapy. Randomization
will take place during the last diagnostic session. Partici-
pants will be randomized using random number tables. A
recruitment flow chart is presented in Fig. 1. Patients
are planned to be enrolled in the study for over a
period of three years. Before participating in the study,
each patient will be provided with written information
about the study and will be invited to give written con-
sent for inclusion. Participants who do not meet the
inclusion criteria will be offered suitable alternative
treatment options.Table 1 Inclusion and exclusion criteria
Inclusion criteria Current diagnosis of Axis I anxiety disorder
(based on the MINI)
Diagnosis of comorbid personality disorder
(based on the SCID II) or depressive disorder
(based on the MINI)
Aged 18 to 65-years-old
Sufficient knowledge of the Polish language
Written informed consent from the patient
Exclusion criteria Organic brain disorder
Acute substance-related disorders
Schizophrenia or bipolar affective disorder
Severe depression (defined as over 26 points on the
Beck Questionnaire)
Cluster A personality disorders
Current suicidal ideation and a high risk of suicide
Restricted intellectual capacity
Serious unstable medical problems or complications
Concurrent psychotherapeutic treatmentInterventions
Interventions will be offered in a daily unit setting, which is
a part of the Wola Center for Mental Health at the district
Wola Hospital in Warsaw. Psychodynamic and cognitive-
behavioral group psychotherapy has been provided at the
Wola Center since 2011. This method was developed by
the current team during the last ten years in another clin-
ical setting. When the research project starts, each group
therapy will be conducted by two therapists trained in
accredited cognitive-behavioral or psychodynamic/psycho-
analytic therapy programs.
As is stated in the informed consent, patients will be
encouraged not to commence any other therapy in the
six-month period after the treatment. In cases of acute
deterioration, crisis intervention will be offered. Due to
ethical reasons we decided not to ask for postponing
other therapy when it seems to be needed. Further treat-
ment choices of the patients will not be controlled.
Short-term intensive psychodynamic group therapy
versus cognitive-behavioral group therapy
Both modality therapists should have at least three years’
experience in working with groups. Comprehensive
treatment manuals prepared by a group of current and
past members of the department’s therapeutic team, who
were personally involved in the study, will be used for
both treatments. The two treatments will be delivered at
the same levels of frequency, defined by the total number
of sessions over the study period. The number of spoken
group therapy sessions lasting 90 minutes for each treat-
ment modality will total 70 to 80 hours over a period of
12 weeks. This is the maximal period of time that can be
reimbursed by insurance companies. Both approaches will
contain additional interventions: psycho-drawing (one ses-
sion per week), movie therapy (one session per week), and
relaxation training (one session per week; see the treatment
weekly schedule in Table 2). They are parts of both manuals
and are aimed to intensify the therapeutic processes.
Treatment will start in the morning hours and end in
the afternoon. According to the Polish health care regu-
lations, patients treated in a day hospital setting should
have a therapeutic program for at least five hours a day.
This study will be conducted in closed-ended groups. The
hospital will provide a small meal during the 45-minute
break between the two 90-minute psychotherapy sessions.
The acceptable limit of absences is five days throughout
the whole treatment. Psychotherapists will receive weekly
supervision by certified supervisors. All spoken psycho-
therapy sessions will be recorded, and a random selection
of 10 % from each therapy will be analyzed by two different
independent raters on protocol adherence. This will ensure
that the essential ingredients are being covered by the ther-
apist and, if not, then the reason for the deviation will be
recorded. The reported deviation will be considered minor
Table 2 Treatment weekly schedule
Timea Monday Tuesday Wednesday Thursday Friday
9:00-10:30 Psychotherapy Relaxation Movie therapy Psycho-drawing Psychotherapy
1 hour 30 minutes 1 hour 30 minutes 1 hour 45 minutes 1 hour 30 minutes 1 hour 30 minutes
10:30-11:15 Meal break Meal break Meal break Meal break Meal break
45 minutes 45 minutes 45 minutes 45 minutes 45 minutes
11:15-12:45 Psychotherapy Psychotherapy Movie therapy Psychotherapy Psychotherapy
1 hour 30 minutes 1 hour 30 minutes 1 hour 1 hour 30 minutes 1 hour 30 minutes
13:00-13:50 50-minute psychiatrist group consultations
aPatients come to the hospital between 8 and 9 am and leave between 1 and 2 pm every day
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the particular group should be excluded from the study.
The Comparative Psychotherapy Process Scale (CPPS)
[34] will be used for this purpose, together with ad-hoc
checklists based on specific group treatment manuals.
The CPPS is designed to assess the distinctive features
of psychodynamic-interpersonal and cognitive-behav-
ioral treatments.
Intervention: short-term intensive psychodynamic group
therapy
The form of short-term intensive psychodynamic group
therapy to be used in this trial has been manualized by the
research team for the study. The manual describes the aims
of the treatment, specifies the therapist’s tasks and pur-
poses, presents the therapist’s interventions, and outlines
the kinds of problems and conflicts that can be found in
this patient group. The manual also provides examples of
session situations that are typically encountered in a day
hospital setting. The manual is based on the team’s experi-
ence and on some elements of available manuals. It is
rooted in the group analysis tradition [59], and is
based on the group analytic psychotherapy manual as
developed by Steinar Lorentzen [47]. The manual was
adapted for the day treatment setting and also draws
on Polish psychoanalytical group experiences as prac-
ticed in public service [58–60, 81]. This approach was
initiated in the 1960s and has evolved since then.
The intervention shares the five basic assumptions of the
psychodynamic approach formulated by Rutan [68]. The
first is psychological determinism: the assumption that our
actions are more or less determined, like our way of per-
ceiving and recognizing. The second is unconscious pro-
cesses, namely that predetermined influences may to a
great degree be unconscious. The third is dynamic and
goal-directed behavior: according to the dual-instinct the-
ory, a person’s behavior serves to protect the individual
from perceived danger or pain, whereas according to the
object-relation theory, the behavior of a person is directed
to reach a relationship and attachment. Psychology of the
self claims that the goal is to formulate and strengthen the
integrated self. The fourth is epigenetic development: theunconscious life of the individual originates in relation to
interpersonal experiences remaining from before. People
are unconsciously forced to repeat those experiences which
are connected with a majority of conflicts and painful ex-
perience. Flaws in early development can be repaired if they
are relived and effectively re-experienced correctively in the
here and now of the transference. Finally, the assumption
that different functions of mind are at work at any time,
and distinct functions (id, ego, superego) may be in conflict
with one another. In this approach, all anxiety disorder
symptoms are understood as an expression of unacceptable
unconscious fantasies and conflicts. This approach also
shares the assumption that the current conflict, which is ac-
tivated under the influence of current life events, is a reflec-
tion of a conflict of the past [48]. Due to the short form of
the therapy, its goals are formulated realistically by taking
into account the symptoms of personality disorders.
The main therapeutic factors are: 1) mirroring, namely
that patients can recognize their own aspects in the
fantasies, behaviors, and problems of other group mem-
bers; 2) sharing, namely that patients share information,
which helps them to understand themselves, their inter-
actions with others, and their own problems; and 3) con-
denser phenomena, namely that unconscious material is
easily expressed through the common influence of group
members on one another. Shared associations help to
understand the symbolic significance of experiences.
Additionally, universal group factors are taken into ac-
count [87]. The therapists use techniques of clarification,
confrontation, and interpretation. As in other psycho-
dynamic short-term therapies, this approach is more
structured. To intensify the therapeutic processes, three
additional techniques are used: 1) memoir, namely that
each patient describes his or her own life story, which
consists of important emotional experiences, and reads it
during one therapeutic session; 2) elements of role playing
and/or psychodrama, namely that the patient presents his
or her way of talking to important persons; 3) a summary,
namely that patients receive written structured feedback
from other patients in the final stage of therapy.
Application of these techniques results from the need
for patients to concentrate on the therapeutic goals and
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disorders. It is characteristic of this type of therapy to
observe and discuss the manner of how a patient inter-
acts with other patients in a group and with the therap-
ist (transference), and afterwards to relate this to the
patient’s functioning in past relations and in other rela-
tions beyond the therapy. A significant factor is explor-
ing and modifying immature defense mechanisms, with
a major focus on the mechanisms of projection and
acting-out, and on increasing the employment of mature
defense mechanisms. The group process is of great im-
portance; it is assumed to have both a conscious and un-
conscious aspect. The course of therapy consists of
phases that are supposed to stimulate various conflicts
in different patients. The therapists are more active here
than in the classical form of group analysis: they employ
interventions more often, such as explaining and naming
reality, and are less focused on patients’ fantasies. In
classic group analysis, the group therapist does not func-
tion as a group leader but as a group conductor, frustrat-
ing regressive needs and thus replacing the leader’s
authority by that of the group: all members interpret,
analyze, and support one another, including the con-
ductor [43].
Intervention: short-term intensive transdiagnostic
cognitive-behavioral group therapy
The short-term intensive transdiagnostic cognitive-be-
havioral group therapy (GCBT) was designed to conduct
treatment in naturalistic settings of diagnostically mixed
anxiety disorder patients with comorbid personality dis-
orders [36]. It is based on the transdiagnostic approach
to emotional disorders, and particularly anxiety disor-
ders, which has been in development for over the past
10 years [4, 5, 55]. Additionally, it includes interventions
for personality disorders based on schema therapy and
modes of personality disorders. This approach assumes
high overlap between anxiety disorders and is focused
on their common aspects. Preliminary data indicate that
GCBT is equally effective in the treatment of individuals
with different anxiety disorders [56].
The short-term intensive GCBT that has been developed
by our group shares the classical assumptions of CBT [6],
namely that the emergence and persistence of psychopatho-
logical symptoms results from maladaptive thinking styles
and cognitive bias (the cognitive model), and maladaptive
behavioral strategies (the behavioral model). Anxiety disor-
ders in particular are described as resulting from distorted
beliefs focused on threat (physical or psychological) and an
elevated sense of personal vulnerability [9]. Therefore,
short-term intensive GCBT, just like standard CBT, is fo-
cused on helping patients identify and modify distorted
cognitions, and on using techniques based on learning prin-
ciples, mainly exposure, to help them eliminate anxiety.Short-term intensive GCBT, similarly to most CBT
therapies, is task-oriented and designed for finding and
solving problems. Among the therapeutic techniques
there are: monitoring and identification of negative auto-
matic thoughts and related emotional experiences, phys-
ical sensations and behaviors (in the form of diaries),
various techniques for restructuring and challenging
dysfunctional thinking, creating a hierarchy of anxiety-
provoking situations, performing exposure (imaginal and
in vivo), behavioral experiments, relaxation techniques,
developing goal-setting and problem-solving skills, and
social skills training [41]. What differentiates GCBT
from CBT is that the strength of group cohesion is
employed, that is, a sense of belonging and confidence
in the group’s members and believing that its goals are
important [77, 87]. GCBT creates a good environment
for such phenomena as modeling, social learning, and
exposure. Participating in the group gives the patient the
opportunity to employ characteristic group therapeutic
factors, such as hope, universality, information sharing,
altruism, corrective recapitulation of primary family ex-
perience, social skills development, and imitation [87].
The GCBT therapy process is divided into modules
that reflect the phases and stages of the therapeutic
process (P Holas and H Suszek, unpublished work). A
weekly schedule includes cognitive therapy and behavioral
therapy (exposure, in vivo) sessions as well as social skills
training, including mainly assertiveness. As a result of
such a schedule, each week consists of four elements: a
homework discussion (weekend task), the presentation of
new material during psychoeducation and therapy ses-
sions, training new skills (examples from the lives of pa-
tients, role play, and exposure), and planning the next
homework assignment. As a result, patients learn new
skills, practice them in a safe environment, and then grad-
ually introduce them into their lives outside the group.
Assessments
Patients are subjected to four assessments: 1) at the
screening; 2) at baseline after randomization; 3) at the end
of the 12-week treatment; and 4) six months after the end
of therapy in order to evaluate the longer-term effects of
the treatments. Patients in the wait-list group will have
one additional assessment at the end of the 12-week wait-
ing period.
Information from the screening will be used to
perform stratified randomization and to validate the
inclusion and exclusion criteria. Patients will be
assessed by independent and trained clinicians who
will remain blind to the treatment conditions, and
who will not be involved in direct clinical care of
any of the patients. Primary outcome measures and
secondary outcome measures can be distinguished in this
study. The primary outcome measures include self-report
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global improvement, and dichotomized diagnosis of anx-
iety disorder (improved or unimproved). The secondary
outcome measures include personality, depression, self-
esteem, defense mechanisms, beliefs about self and others,
interpersonal problems, object relations, parental bonding,
meta-cognition, and quality of life. The following sociode-
mographic data will be collected: sex, age, marital status,
education, past treatments, symptom history, and medica-
tion. We will also examine patients’ expectancy toward
change and treatment. Some of the variables, such as the
presence or absence of a personality disorder, will be
treated in exploratory analyses as predictors and modera-
tors of treatment response. The time points of assessment
and measures are presented in Table 3.
Instruments
Primary measures
The following instruments will be used:
1. State-Trait Anxiety Inventory (STAI) [72, 86]. The
STAI measures a person’s situational (or state)Table 3 Instruments at different assessment points
Instrument Screening Baseline End of Treatment 6-Month Follow-up
STAI X X X
HAM-A X X X
CGI-S X X X
CGI-I X X X
M.I.N.I. X X X
SCID-II X
BDI-II X X X
OQ-45 X X X
SES X X X
DSQ-40 X X X
PBQ X X X
IIP X X X
DWM-S X X X
ECR X X X
BORRTI X X X
MCQ X X X
SWLS X X X
CEQ X
STAI: State-trait anxiety inventory; HAMA-A: Hamilton anxiety rating scale;
CGI-S: Clinical global impression - severity scale; CGI-I: Clinical global
impression - improvement scale; M.I.N.I.: Mini-international neuropsychiatric
interview 5; SCID II: Structured clinical interview for DSM-IV personality
disorders questionnaire; BDI-II: Becks depression inventory II; OQ-45: Outcome
questionnaire; SES: Self-esteem scale; DSQ-40: Defense style questionnaire;
PBQ: Personality beliefs questionnaire; IIP: Inventory of interpersonal problems;
DWM-S: Dysfunctional working models scale; ECR: Experiences in close
relationships; BORRTI: Bell object relations and reality testing inventory; MCQ:
Meta-cognitions questionnaire; SWLS: Satisfaction with life scale. CEQ:
Credibility/Expectancy questionnaireanxiety, as well as the amount of anxiety a person
generally feels most of the time (trait). The two
self-report scales contain 20 items each.
2. Hamilton Anxiety Rating Scale (HAM-A) [33]. The
HAM-A is an interviewer-administered and rated
measure of the severity of anxiety symptoms. The
scale consists of 14 items, each defined by a series of
symptoms, and measures both psychic anxiety
(mental agitation and psychological distress) and
somatic anxiety (physical complaints related to
anxiety).
3. Clinical Global Impression - Severity scale (CGI-S)
[32]. The CGI-S is a seven-point scale which requires
that the clinician rate the severity of the patient’s illness
at the time of assessment, relative to the clinician’s past
experience with patients who have the same diagnosis.
4. Clinical Global Impression - Improvement scale
(CGI-I) [32]. The CGI-I is a seven-point scale which
requires that the clinician assess how much the
patient’s illness has improved or worsened, relative
to a baseline state at the beginning of the
intervention.
5. Mini-International Neuropsychiatric Interview 5
(MINI) [51, 71]. The MINI is a short diagnostic
interview based on the DSM-IV criteria, which
focus on the existence of current psychiatric
disorders. It consists of separate modules to
diagnose specific disorders.
Secondary measures
The following instruments will be used:
1. Structured Clinical Interview for DSM-IV Personality
Disorders Questionnaire (SCID-II) [24, 25]. The
SCID-II is an observer-based diagnostic interview
used to determine DSM-IV Axis II disorders.
2. Becks Depression Inventory II (BDI-II) [8]. The
BDI-II is a 21-item self-report inventory used to
assess DSM-IV depressive symptoms. Each item
consists of four statements indicating increasing
symptom severity.
3. Outcome Questionnaire (OQ-45) [28, 45]. The
OQ-45 consists of 45 items and is designed to
evaluate a broad range of psychological problems
and symptoms of psychopathology. It contains
three subscales: 1) symptom distress, 2)
interpersonal relations; and 3) social role.
4. Self-Esteem Scale (SES) [22, 67]. The SES is a 10-item
self-report scale that measures global self-worth by
measuring both positive and negative feelings about
the self.
5. Defense Style Questionnaire (DSQ-40) [1, 13]. The
DSQ-40 is a 40-item self-report questionnaire
designed to measure an individual’s propensity
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neurotic, and immature), along with 20 individual
defense mechanisms.
6. Personality Beliefs Questionnaire (PBQ) [7]. The
PBQ is a 126-item self-report measure of beliefs
associated with 10 DSM-III-R and DSM-IV
personality disorders (represented as subscales):
1) avoidant; 2) dependent; 3) obsessive-compulsive;
4) histrionic; 5) passive-aggressive; 6) narcissistic;
7) paranoid; 8) schizoid; 9) antisocial, and 10)
borderline.
7. Inventory of Interpersonal Problems (IIP) [37]. The IIP
is a 64-item self-report questionnaire that inventories
the interpersonal problems that people experience. It
contains eight scales that assess different aspects of an
individual’s interpersonal difficulties: 1) domineering/
controlling; 2) vindictive/self-centered; 3) cold/distant;
4) socially inhibited; 5) non-assertive; 6) overly
accommodating; 7) self-sacrificing; and 8) intrusive/
needy.
8. Dysfunctional Working Models Scale (DWM-S)
[54, 62]. The DWM-S is a 35-item self-report
measure of dysfunctional working models of the
self and others.
9. Experiences in Close Relationships (ECR) [14, 74].
The ECR is a 36-item self-report measure of adult
attachment. It groups people into four different
categories on the basis of scores along two scales:
avoidance and anxiety.
10. Bell Object Relations and Reality Testing
Inventory (BORRTI) [10, 73]. The BORRTI is a
45-item self-report measure designed to evaluate
the ability to sustain essential relationships and
to accurately identify internal and external
reality.
11. Meta-Cognitions Questionnaire (MCQ) [17, 29].
The MCQ is a 65-item self-report scale developed to
assess several dimensions of metacognition that is
thought to be relevant to psychopathology. Its five
subscales are: 1) positive beliefs about worry;
2) negative beliefs about thoughts concerning
uncontrollability and danger; 3) cognitive confidence
(assessing confidence in attention and memory);
4) negative beliefs concerning the consequences of
not controlling thoughts, and 5) cognitive
self-consciousness (the tendency to focus attention
on thought processes).
12. Satisfaction With Life Scale (SWLS) [20, 41]. The
SWLS is a five-item self-report global measure of life
satisfaction.
13. Credibility/Expectancy Questionnaire (CEQ) [18].
The CEQ is used to measure expectancy for change
and treatment credibility as potential confounds for
outcome. It is comprised of six questions.Record retention and confidentiality
Epidemiological, clinical, and all outcome data from
each patient will be recorded in an electronic data-
base by a clinician responsible for the study. All re-
cords will be stored for 10 years from the date of
the last study publication. All computer databases
will include a unique participant identifier and not
the participant’s name and address. Consent forms
and other documents, including the participant’s
name, will be stored separately from the question-
naires and other trial documents in locked cabinets.
Withdrawal from the trial
Participants may voluntarily withdraw from the trial for
any reason. A patient’s withdrawal from the trial will not
affect that patient’s access to treatment.
Sample size calculation
The sample size calculation was based on previous trials
showing the effectiveness of group CBT or psycho-
dynamic group therapy in anxiety and personality disor-
ders; however, very few studies of this kind have been
conducted. Additionally, we decided to base our study
on trials showing the effectiveness of group psychother-
apy in general, and on trials showing the effectiveness of
group psychotherapy in day hospitals.
Burlingame et al. [15] estimated the effectiveness of
group psychotherapy in a meta-analysis of 111 experi-
mental and quasi-experimental studies that were pub-
lished over the past 20 years. Based on 51 studies which
compared active group treatment versus a wait-list con-
trol, the reported average effect size was 0.58. Effect
sizes for comparisons with a wait-list control for differ-
ent diagnoses and therapeutic orientations were not re-
ported. Petrocelli [62] employed a meta-analysis to
examine the effectiveness of GCBT based on 12 studies,
in which GCBT was compared with no treatment. The
average weighted mean effect size for GCBT versus no
treatment was 0.59. Wersebe et al. [82] conducted a meta-
analysis for the effectiveness of GCBT for social anxiety dis-
order. The inclusion of 11 RCTs comparing interventions
with control conditions showed a pooled effect size of 0.53
in favour of the interventions. A review conducted by the
Centre for Psychological Services Research at the University
of Sheffield to assess evidence for the efficacy and effective-
ness of psychodynamic group therapy (including group
analysis) identified 37 studies [11, 12]. Only one study in-
cluded the wait-list control [78], but was limited to binge-
eating disorder patients. Knijnik et al. [44] conducted an
RCT which showed that patients with generalized social
phobia treated with psychodynamic group therapy im-
proved significantly on their social anxiety symptoms as
compared to the placebo group, showing an effect size of
0.83. The most similar trials to ours are two RCTs reported
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as a component of day treatment [2, 50, 63]. The first study
found that day care patients suffering from affective disor-
ders and personality disorders experienced a significant im-
provement as compared to patients in the wait-list control
group [63]. The mean effect size for 17 outcome variables
was 0.71. In the second study, day care treatment (18-week
group psychodynamic and cognitive-behavioral psychother-
apy) was compared to individual psychotherapy in patients
with personality disorders [2]. No significant differences in
improvement were observed between the two groups.
The effects of the intervention on symptoms of anxiety
are the primary outcome measures in our study. Al-
though the study’s general aim is to compare both treat-
ments with the wait list, an additional comparison has
been planned of both treatments on the outcomes.
Comparison between all three groups is possible for two
subsequent measurements. Due to ethical reasons, sub-
jects from the wait list will start therapy soon after the
second measurements and will not be available to par-
ticipate in the study during the third measurement. As a
result, that data will be analyzed in a 3 × 2 experimental
plan (three groups available for two repeated measures)
and in a 2 × 3 experimental plan (two groups available
for three repeated measures). Based on the trials men-
tioned above, we assumed that we would be able to
show the differences between the interventions and the
control conditions with a standardized effect size of 0.58
(the lowest value effect size presented in the literature)
for continuous outcomes. As this effect size was Cohen’s
d suited for t-test comparisons, we conducted a conver-
sion into f suited for analysis of variance (f = 0.29). The
sample size was calculated using the G*power software
program [23]. Assuming an alpha of 0.05, with a power
(1-β) of 0.80, a minimum number of 96 patients is re-
quired for a 2 × 3 experimental plan, and a minimum
number of 120 patients is required for a 3 × 2 experi-
mental plan. Furthermore, for the purpose of being able
to identify the difference between the two treatments,
we followed the design of the most similar study [2] and
assumed effect sizes of 0.24 for continuous outcomes,
which leads to a total sample size of 171 participants for
a 3 × 2 experimental plan and a total sample size of 140 par-
ticipants for a 2 × 3 experimental plan. We will also test
possible within-between group interaction, however its ef-
fect size is not available in literature. We assumed a medium
effect size for the interaction (f = 0.25), which needs 156 par-
ticipants in a 2 × 3 plan and 159 participants in a 3 × 2 plan.
Assuming that there is a dropout rate of 25 %, this means
that 199 participants will need to be recruited.
Statistical analysis
All data analyses will be performed using SPSS Statistics
software v21.0 (IBM Corporation, Armonk, NY, USA). Allrandomized patients will be analyzed, including those who
stop receiving treatment, on an intention-to-treat (ITT) as
well as treatment-completer basis. The multiple imputation
method will be used for missing data when appropriate.
Analyses of variance with repeated measures (three meas-
urement points: pre, post, and follow-up) will be applied
for continuous data (primary outcomes: STAI, HAM-A,
CGI-S, and CGI-I; secondary outcomes: BDI-II, OQ-45,
SES, DSQ-40, PBQ, IIP, DWM-S, ECR, BORRTI; MCQ, and
SWLS). Primary planned comparison is the interaction be-
tween the time (pre-to-post and post-to-follow-up change
on anxiety) and group variables (CBT versus wait list; PDT
versus wait list). Chi-squared tests will be applied for dichot-
omous data (MINI). Additionally, random effects models
for repeated measures will be used. Multiple regression ana-
lyses will be applied to test moderators of change that is to
show whether each of the interventions is more effective for
some groups of patients (interventions, diagnoses, combin-
ation of diagnoses and baseline measurements as predic-
tors). Multiple regression analyses will be also applied to
search for mediators of change that are theory-specific (for
example, changes in beliefs for CBT and changes in defense
mechanisms for psychodynamic therapy). We will take into
account to what extent the patients were exposed to the
intervention by analyzing the dose-effect relationship.
Discussion
This study examines whether day treatment based on
short-term intensive group therapy is effective. A further
objective is to examine which of the two therapy modalities,
psychodynamic or cognitive-behavioral, is more effective.
We also plan to examine the predictors, moderators, and
mediators of therapeutic change. The current study has
several strengths.
Despite a large number of RCT studies showing the ad-
vantages of using psychodynamic therapy and CBT for
anxiety disorders and personality disorders [35, 70], there
is still insufficient evidence for the efficacy of the group
forms of these approaches, especially the psychodynamic
orientation. Most studies show that the efficacy of treating
anxiety disorders with cognitive-behavioral group therapy
is comparable to its individual form [31, 53, 66, 69, 84].
There is still a lack of similar group versus individual com-
parisons for the psychodynamic approach [15].
A meta-analysis conducted by Tolin [79] that examined
the effectiveness of CBTand other therapies showed the su-
periority of CBT over alternative therapies among patients
with anxiety or depressive disorders. A recent meta-analysis
by Baardseth et al. [3] showed no differences between CBT
and non-CBT treatments for anxiety disorders. In those
analyses, however, almost none of the trials were completed
in community settings.
Group psychotherapy as day treatment differs from
outpatient therapy in intensity (usually five sessions per
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been only two RCTs [2, 63] comparing psychodynamic
group psychotherapy and cognitive-behavioral group
psychotherapy as components of day treatment with
outpatient therapy. However, neither of the studies ad-
dressed anxiety disorders.
There have been several studies about the efficacy of day
treatment of anxiety disorders in Poland [13, 49, 75, 83, 85].
These studies show promising results, however, none of
them were RCTs. This will be the first RCT to evaluate
manualized psychodynamic group therapy and cognitive
behavioral group therapy in a day treatment setting for
people with anxiety disorders. The design of the study
overcomes the disadvantages of previous studies in that it
provides a randomized controlled design, consists of a large
sample size, adequate inclusion criteria, an adequate treat-
ment protocol, and a clear separation of intervention
conditions.
Another strong aspect of the study is its external val-
idity, since the comorbidity of anxiety disorders with
depressive and/or personality disorders is controlled.
Furthermore, the results may be highly generalizable as
the intervention is studied in its natural setting, and
recruitment strategies of both the study and the day
hospitals are very similar. The study combines the ele-
ments of RCTs and naturalistic studies. The study results
may be of great relevance to the health care policy, health
insurance companies, and boards of psychotherapists, and
may contribute to improving the quality of treatment and
to a reduction in health care costs. This issue is relevant
to the Polish health care system, in which evidence-based
practice standards are becoming more important and
institutionally acknowledged. Another strong point of
this study is the broad array of outcome estimates,
which will allow us to measure the effects of treatment
in many areas of life.
Many variables and outcome measures may also be
tested as moderators of change, such as a particular anx-
iety disorder or a particular combination of diagnoses,
self-concept, and parental bonding. Furthermore, by hav-
ing a broad range of outcome measures, our study will
offer an opportunity to look at the mediators of change
that are theory-specific (such as changes in beliefs for
CBT and changes in defense mechanisms for psycho-
dynamic therapy). It would be interesting to test whether
there are shared mechanisms of change.
We recognize a number of limitations in this study
and suggest improvements for future research. First,
generalizing the research findings will be limited because
the trial will be a single-center RCT; future multi-center
trials are needed. Second, having a passive wait-list con-
trol group does not offer the best control for the effects
of expectancy. By including the condition of a placebo
control in which no intervention is given but only thesupport of a therapist (support group), we would be able
to examine the non-specific effects of group interven-
tions, such as social cohesion and expectation of gain.
An active control group is not possible because patients
would have to take three months off of work and this
period would not be covered by their insurance. Another
limitation of this study concerns the use of self-report
instruments as outcome measures.
The last two limitations are related to the complexity
of the interventions and treatment setting. Both treat-
ments consist of many elements, of which verbal psy-
chotherapy is only one. Therefore, it is not possible to
tease out whether potential changes can be attributed to
psychotherapy or to other aspects of the interventions.
We also do not control the exact time that patients will
show up every day at the hospital before therapy, and
the time when they leave the ward after therapy. This
limitation is connected with the formal requirements of
the Polish health care system.Trial status
Trial recruitment is anticipated to begin in September
2015.Endnotes
1SCID criteria for personality disorders and MINI
criteria for anxiety disorders will be additionally verified
with the DSM-V.
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